Reply to L. Marandino et al.
Publication
, Journal Article
Dzimitrowicz, HE; Armstrong, AJ
Published in: J Clin Oncol
July 1, 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
July 1, 2022
Volume
40
Issue
19
Start / End Page
2175 / 2176
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Dzimitrowicz, H. E., & Armstrong, A. J. (2022). Reply to L. Marandino et al. J Clin Oncol, 40(19), 2175–2176. https://doi.org/10.1200/JCO.22.00337
Dzimitrowicz, Hannah E., and Andrew J. Armstrong. “Reply to L. Marandino et al.” J Clin Oncol 40, no. 19 (July 1, 2022): 2175–76. https://doi.org/10.1200/JCO.22.00337.
Dzimitrowicz HE, Armstrong AJ. Reply to L. Marandino et al. J Clin Oncol. 2022 Jul 1;40(19):2175–6.
Dzimitrowicz, Hannah E., and Andrew J. Armstrong. “Reply to L. Marandino et al.” J Clin Oncol, vol. 40, no. 19, July 2022, pp. 2175–76. Pubmed, doi:10.1200/JCO.22.00337.
Dzimitrowicz HE, Armstrong AJ. Reply to L. Marandino et al. J Clin Oncol. 2022 Jul 1;40(19):2175–2176.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
July 1, 2022
Volume
40
Issue
19
Start / End Page
2175 / 2176
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences